• Bitte beachten Sie, dass wir wegen der Feiertage zwischen dem 19.12.2019 und dem 03.01.2020 keine Ware ausliefern. Bestellungen für Lieferungen in 2020 aber nehmen wir gern auch in diesem Zeitraum entgegen.

Produkte von Innaxon

Innaxon

Innaxon ist ein Unternehmen in Tewkesbury in Großbritannien, das sich auf Produkte zum Thema angeborene Immunität fokussiert, wie TLR-Agonisten und niedermolekulare Inhibitoren.

1 von 6 Seiten
Für die Filterung wurden keine Ergebnisse gefunden!
Monophosphoryl Lipid A [MPLA] from E. coli R515 (Re) TLRpure Sterile Solution
Monophosphoryl Lipid A [MPLA] from E. coli R515 (Re)...

Artikelnummer: IAX-100-003-M001

Optimal concentration is dependent upon cell type, species, desired activation and analysis: 0.1-1.0 µg/ml. Does not activate any TLR other than TLR4 as tested up to 50 µg/ml in relevant cellular systems (macrophages). Activation of cells by LPS is mediated by the Toll-like receptor 4 (TLR4), a member of the highly...
Schlagworte: Monophosphoryl Lipid A [MPLA] derived from E. coli R515 (Re) LPS (biosynthetic)
Anwendung: TLR4 activator
ab 119,00 €
Bewerten
G-type iODN (inhibitory ODN) Endotoxin-free (sterile)
G-type iODN (inhibitory ODN) Endotoxin-free (sterile)

Artikelnummer: IAX-200-052-M001

Potent sequence of an inhibitory ODN of the poly-G class I targeting TLR9, but without effect on TLR7 and TLR8 signaling, for in vivo use in rodents (50-150 µg per injection). Negative control: Neutral-ODN (Cat. No.: IAX-200-202).
Schlagworte: Inhibitory ODN (iODN): Class I
Anwendung: TLR9 competitor
MW: 6735 D
ab 94,00 €
Bewerten
ODN 2138 (Control for ODN 1826) Endotoxin-free (sterile)
ODN 2138 (Control for ODN 1826) Endotoxin-free (sterile)

Artikelnummer: IAX-200-201-C100

Negative control GpC ODN for in vivo use in rodents (50-150 µg per injection). As active compound use CpG ODN 1826 (Cat. No.: IAX-200-002). For negative control without agonistic nor antagonistic activity: Neutral-ODN (Cat. No.: IAX-200-202).
Anwendung: Negative Control for ODN 1826 (IAX-200-002)
MW: 6383 D
94,00 €
Bewerten
Polyinosinic-polycytidylic acid [Poly(I:C)] Endotoxin-free (sterile)
Polyinosinic-polycytidylic acid [Poly(I:C)]...

Artikelnummer: IAX-200-021-M005

Activates TLR3, MDA5/Helicard and RIG-I. Optimal working concentration depends upon target receptor accessibility, number, density, as well as cell type, and therefore needs to be determined for each application. Recommended concentration range: in vitro: 0.5-10 µg/ml, in vivo: 5mg/kg.
Schlagworte: Polyinosinic-polycytidylic acid, potassium salt (poly (I:C))
Anwendung: TLR3, MDA5/Helicard, RIG-I activator
ab 108,00 €
Bewerten
ODN 1668 (Type B) Endotoxin-free (sterile)
ODN 1668 (Type B) Endotoxin-free (sterile)

Artikelnummer: IAX-200-001-M001

3 x 1 mg. Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.6-6.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 1720 (Cat. No.: IAX-200-200).
Schlagworte: CpG ODN TLR9 Agonist: B Type (species: rodent)
Anwendung: TLR9 activator
MW: 6383 D
ab 119,00 €
Bewerten
ODN M362 (Type C) Endotoxin-free (sterile)
ODN M362 (Type C) Endotoxin-free (sterile)

Artikelnummer: IAX-200-004-M001

Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.6-6.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 2243 (Cat. No.: IAX-200-205).
Schlagworte: CpG ODN TLR9 Agonist: A Type (species: human and rodent)
Anwendung: TLR9 activator
MW: 6644 D
ab 119,00 €
Bewerten
IAXO-101 (CD14/TLR4 Antagonist) (synthetic)
IAXO-101 (CD14/TLR4 Antagonist) (synthetic)

Artikelnummer: IAX-600-001-M001

Described to interfere with human, rat and mouse TLR4/CD14 signaling, other species not tested. Optimal working concentration depends upon the type, purity and concentration and of TLR4 ligand, carrier protein such as LPS-binding protein (LBP), soluble and membrane-bound CD14, the presence of TLR4 co-receptors (e.g....
Schlagworte: Methyl 6-deoxy-6-N-dimethyl-N-cyclopentylammonium-2,3-di-O-tetradecyl-?-D-glucopyranoside iodide
Anwendung: CD14/TLR4 Antagonist
CAS 1202388-64-4
MW: 810.02 D
ab 227,00 €
Bewerten
LPS (Universal) from S. abortus equi (S-form) TLRpure Sterile Solution
LPS (Universal) from S. abortus equi (S-form) TLRpure...

Artikelnummer: IAX-100-009-M001

Optimal concentration is dependent upon cell type, species, desired activation and analysis: 0.01-1.0 µg/ml. Does not activate any TLR other than TLR4 as tested up to 50 µg/ml in relevant cellular systems (macrophages). Activation of cells by LPS is mediated by the Toll-like receptor 4 (TLR4). For optimal...
Schlagworte: Lipopolysaccharide (LPS) from Salmonella abortus equi, S-type (smooth/wild-type) LPS
Anwendung: TLR4 activator
ab 90,00 €
Bewerten
ODN 1826 (Type B) Endotoxin-free (sterile)
ODN 1826 (Type B) Endotoxin-free (sterile)

Artikelnummer: IAX-200-002-M001

Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.6-6.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 1982 (Cat. No.: IAX-200-201).
Schlagworte: CpG ODN TLR9 Agonist: B Type (species: rodent)
Anwendung: TLR9 activator
Reaktivität: Mouse, Rat
MW: 6383 D
ab 119,00 €
Bewerten
ODN 2006 (Type B) Endotoxin-free (sterile)
ODN 2006 (Type B) Endotoxin-free (sterile)

Artikelnummer: IAX-200-006-M001

3 x 1 mg. Optimal concentration is dependent upon cell type, species, desired activation and analysis: in vitro 0.1-1 µM (~0.7-7.0 µg/ml), in vivo 50-250 µg in rodent animal models. Negative control: GpC ODN 2137 (Cat. No.: IAX-200-206).
Schlagworte: CpG ODN TLR9 Agonist: B Type (species: human and rodent)
Anwendung: TLR9 activator
MW: 7720 D
ab 119,00 €
Bewerten
LPS from E. coli O111:B4 (S-form) TLRpure Sterile Solution
LPS from E. coli O111:B4 (S-form) TLRpure Sterile Solution

Artikelnummer: IAX-100-012-C500

Optimal concentration is dependent upon cell type, species, desired activation and analysis: 0.01-1.0 µg/ml. Does not activate any TLR other than TLR4 as tested up to 50 µg/ml in relevant cellular systems (macrophages). Activation of cells by LPS is mediated by the Toll-like receptor 4 (TLR4). For optimal...
Schlagworte: Lipopolysaccharide (LPS) from E. coli O111:B4, S-type (smooth/wild-type) LPS
Anwendung: TLR4 activator
ab 173,00 €
Bewerten
LPS from E. coli O55:B5 (S-form) TLRpure Sterile Solution
LPS from E. coli O55:B5 (S-form) TLRpure Sterile Solution

Artikelnummer: IAX-100-013-M001

Optimal concentration is dependent upon cell type, species, desired activation and analysis: 0.01-1.0 µg/ml. Does not activate any TLR other than TLR4 as tested up to 50 µg/ml in relevant cellular systems (macrophages). Activation of cells by LPS is mediated by the Toll-like receptor 4 (TLR4). For optimal...
Schlagworte: Lipopolysaccharide (LPS) from E. coli O55:B5, S-type (smooth/wild-type) LPS
Anwendung: TLR4 activator
ab 173,00 €
Bewerten
1 von 6 Seiten
Zuletzt angesehen